Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Thompson

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2012
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trialA F C Okines, L C Thompson, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2013
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trialsA F C Okines, D Gonzalez de Castro, D Cunningham, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2012
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trialA F C Okines, L C Thompson, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2013
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trialsA F C Okines, D Gonzalez de Castro, D Cunningham, et al.
Pageof 3